Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001823239-24-000118
Filing Date
2024-11-12
Accepted
2024-11-12 17:24:31
Documents
87
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrvi-20240930.htm   iXBRL 10-Q 1618427
2 EX-31.1 mrvi-q32024form10xqxex311x.htm EX-31.1 8888
3 EX-31.2 mrvi-q32024form10xqxex312x.htm EX-31.2 8819
4 EX-32.1 mrvi-q32024xform10xqxex321.htm EX-32.1 4782
5 EX-32.2 mrvi-q32024xform10xqxex322.htm EX-32.2 4723
  Complete submission text file 0001823239-24-000118.txt   8543071

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20240930.xsd EX-101.SCH 53870
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrvi-20240930_cal.xml EX-101.CAL 92992
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrvi-20240930_def.xml EX-101.DEF 341002
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20240930_lab.xml EX-101.LAB 677841
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20240930_pre.xml EX-101.PRE 506189
89 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20240930_htm.xml XML 1252122
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39725 | Film No.: 241450005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)